Literature DB >> 24134468

Acne is an inflammatory disease and alterations of sebum composition initiate acne lesions.

C C Zouboulis1, E Jourdan, M Picardo.   

Abstract

Hyperseborrhoea has been considered as a major aetiopathogenetic factor of acne. However, changes in sebaceous gland activity not only correlate with seborrhoea but also with alterations in sebum fatty acid composition. Current findings indicate that sebum lipid fractions with proinflammatory properties and inflammatory tissue cascades are associated in the process of the development of acne lesions. The oxidant/antioxidant ratio of the skin surface lipids and alterations of lipid composition are the main players in the induction of acne inflammation. Nutrition may influence the development of seborrhoea, the fractions of sebum lipids and acne. Acne is an inflammatory disease probably triggered, among others, by proinflammatory sebum lipid fractions.
© 2013 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2013        PMID: 24134468     DOI: 10.1111/jdv.12298

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  51 in total

1.  Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes.

Authors:  Attila Oláh; Balázs I Tóth; István Borbíró; Koji Sugawara; Attila G Szöllõsi; Gabriella Czifra; Balázs Pál; Lídia Ambrus; Jennifer Kloepper; Emanuela Camera; Matteo Ludovici; Mauro Picardo; Thomas Voets; Christos C Zouboulis; Ralf Paus; Tamás Bíró
Journal:  J Clin Invest       Date:  2014-07-25       Impact factor: 14.808

2.  Short lipopeptides specifically inhibit the growth of Propionibacterium acnes with a dual antibacterial and anti-inflammatory action.

Authors:  Guang Yang; Jingyu Wang; Shengsheng Lu; Zhao Chen; Sheng Fan; Daiwei Chen; Huanxin Xue; Wenyuan Shi; Jian He
Journal:  Br J Pharmacol       Date:  2019-05-17       Impact factor: 8.739

3.  Short-Chain Fatty Acids from Cutibacterium acnes Activate Both a Canonical and Epigenetic Inflammatory Response in Human Sebocytes.

Authors:  James A Sanford; Alan M O'Neill; Christos C Zouboulis; Richard L Gallo
Journal:  J Immunol       Date:  2019-02-08       Impact factor: 5.422

4.  Stemming the tide of antimicrobial resistance: implications for management of acne vulgaris.

Authors:  Miriam Santer; Nick A Francis; Duncan Platt; Elizabeth Anne Eady; Alison M Layton
Journal:  Br J Gen Pract       Date:  2018-02       Impact factor: 5.386

5.  [Acne vulgaris].

Authors:  C C Zouboulis
Journal:  Hautarzt       Date:  2014-08       Impact factor: 0.751

Review 6.  Beyond acne: Current aspects of sebaceous gland biology and function.

Authors:  Christos C Zouboulis; Mauro Picardo; Qiang Ju; Ichiro Kurokawa; Dániel Törőcsik; Tamás Bíró; Marlon R Schneider
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

7.  Short lipopeptides specifically inhibit the growth of Propionibacterium acnes with dual antibacterial and anti-inflammatory action.

Authors:  Guang Yang; Jingyu Wang; Shengsheng Lu; Zhao Chen; Sheng Fan; Daiwei Chen; Huanxin Xue; Wenyuan Shi; Jian He
Journal:  Br J Pharmacol       Date:  2019-04-15       Impact factor: 8.739

Review 8.  Common Pathogenesis of Acne Vulgaris and Atherosclerosis.

Authors:  Hao Jiang; Changyi Li
Journal:  Inflammation       Date:  2019-02       Impact factor: 4.092

9.  Mustard vesicants alter expression of the endocannabinoid system in mouse skin.

Authors:  Irene M Wohlman; Gabriella M Composto; Diane E Heck; Ned D Heindel; C Jeffrey Lacey; Christophe D Guillon; Robert P Casillas; Claire R Croutch; Donald R Gerecke; Debra L Laskin; Laurie B Joseph; Jeffrey D Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2016-04-26       Impact factor: 4.219

10.  Use of lipidomics to investigate sebum dysfunction in juvenile acne.

Authors:  Emanuela Camera; Matteo Ludovici; Sara Tortorella; Jo-Linda Sinagra; Bruno Capitanio; Laura Goracci; Mauro Picardo
Journal:  J Lipid Res       Date:  2016-04-27       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.